US Patent Issued to BWXT Medical on June 23 for "Method for determination of Actinium-227 in Actinium-225" (Canadian Inventor)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,663,551, issued on June 23, was assigned to BWXT Medical Ltd. (Ottawa).

"Method for determination of Actinium-227 in Actinium-225" was invented by Stephen M. Oelsner (Carleton Place, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for determination of Actinium-227 (Ac-227) via indirectly produced Ra-225/Ac-225 parent/daughter. The determination of Ac-227 or its decay daughters can be used as a "pre-release" quality control test for total Ac-227 content."

The patent was filed on Dec. 27, 2023, under Application No. 18/397,165.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-...